Wilson Sonsini Goodrich & Rosati represented LENZ in the transaction. Biopharmaceutical company LENZ Therapeutics announced that it raised $83.5 million in an oversubscribed Series B financing....
LENZ Therapeutics’ $83.5 Million Series B Financing
Prime Therapeutics’ Acquisition of Magellan Rx from Centene
Skadden advised Centene Corporation in the deal. McDermott Will & Emery represented Prime Therapeutics LLC. Centene Corporation signed its definitive agreement to sell Magellan Rx to...
Excision BioTherapeutics’ $60 Million Financing
Wilson Sonsini Goodrich & Rosati advised Excision BioTherapeutics on the deal. Excision BioTherapeutics, a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives,...



























